Effect of Dapagliflozin on Blood Pressure Variability in Patients With Prediabetes and Prehypertension Without Pharmacological Treatment
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 15 Feb 2018
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Hypertension; Prediabetic-state; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 13 Feb 2018 Planned End Date changed from 1 Nov 2017 to 1 May 2018.
- 13 Feb 2018 Status changed from recruiting to active, no longer recruiting.
- 03 Jan 2017 New trial record